Ignite Creation Date:
2025-12-24 @ 3:57 PM
Ignite Modification Date:
2026-01-24 @ 12:23 PM
Study NCT ID:
NCT03158792
Status:
COMPLETED
Last Update Posted:
2017-09-11
First Post:
2017-04-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function
Sponsor:
Lebanese American University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-24
Start Date Type:
ACTUAL
Primary Completion Date:
2017-07-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07-13
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-09
First Submit QC Date:
None
Study First Post Date:
2017-05-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-09-08
Last Update Post Date:
2017-09-11
Last Update Post Date Type:
ACTUAL